Streetbeat News

Stock Prices

TNFA

TNF Pharmaceuticals has secured a strategic equity investment from Prevail Partners, LLC, priced at a 40% premium to the market. Prevail InfoWorks, Inc. will act as the Clinical Research Organization partner, ensuring TNF Pharmaceuticals is fully funded for clinical trials for the next two years.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:15 pm

TSLA

Tesla shares declined following the release of Q3 delivery and production figures, indicating potential investor concerns over the company's performance.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:14 pm

STLA

FCA US LLC reported a 20% year-over-year decrease in Q3 2024 U.S. sales, totaling 305,294 vehicles. Despite the decline, the company's market share increased from 7.2% in July to 8% in September, and inventory was reduced by 50K units. Incentives will continue across brands like Chrysler, Dodge, FIAT, Jeep, and Ram.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:13 pm

MULN

Mullen Automotive anticipates a Q3 2024 revenue of $4.5 million and plans to reduce cash burn through 2025, aiming for cash breakeven by December 2025.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:12 pm

AAPL

BABA

NVDA

Jim Cramer advises investors to let 'hot money' flow out of Nvidia and Apple, suggesting potential short-term declines due to high valuations and post-iPhone slump. He recommends considering Alibaba for those looking at Chinese markets, citing its solid fundamentals despite regulatory challenges.

Portfolio Pulse from Surbhi Jain

October 02, 2024 | 1:11 pm

ELYM

Eliem Therapeutics is rebranding to Climb Bio, Inc. and will trade under the new symbol 'CLYM' on Nasdaq starting October 3, 2024. This change aligns with their new focus on immune-mediated diseases after acquiring Tenet Medicines.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:11 pm

FTDS

REGL

RPM

RPM International Inc (NYSE:RPM) reported a decline in sales but beat EPS expectations, leading to a rise in share price. Despite global headwinds, the company showed strong cash flow and liquidity. RPM expects flat sales in Q2 but anticipates EBIT growth. Investors can access RPM through ETFs like REGL and FTDS.

Portfolio Pulse from Lekha Gupta

October 02, 2024 | 1:10 pm

JNJ

Johnson & Johnson announced that their drug ERLEADA shows a significant survival benefit over enzalutamide in treating metastatic castration-sensitive prostate cancer, reducing the risk of death by 23% at 24 months. This was presented at the European Congress of Oncology Pharmacy.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:09 pm

ADM

FANG

LFUS

MKC

NNE

Jim Cramer provided stock recommendations on CNBC's 'Mad Money Lightning Round.' He advised buying McKesson Corporation, while expressing concerns about NANO Nuclear Energy, Diamondback Energy, Littelfuse, and Archer-Daniels-Midland. Analysts have also adjusted price targets for these companies.

Portfolio Pulse from Avi Kapoor

October 02, 2024 | 1:08 pm

MARA

Marathon Digital Holdings Inc (NASDAQ:MARA) reported a 5% increase in Bitcoin production for September, mining 705 BTC. The company also increased its hash rate by 5% and aims to reach 50 EH/s by year-end. Marathon remains committed to environmental transparency, submitting a disclosure to the Climate Disclosure Project.

Portfolio Pulse from Adam Eckert

October 02, 2024 | 1:04 pm